L04AA03 • anti-lymphocyte immunoglobulin (horse) • Antineoplastic and immunomodulating agents | Immunosuppressants | Selective immunosuppressants
Horse anti-lymphocyte immunoglobulin is used for the prevention and treatment of acute rejection in organ transplantation. It works by suppressing the body's immune response, reducing T-lymphocyte activity.
The medication is administered intravenously, as directed by a doctor. It is important to monitor the patient for adverse reactions during the infusion.
Side effects may include fever, chills, skin rashes, or injection site reactions. In rare cases, severe allergic reactions or opportunistic infections may occur.
Horse anti-lymphocyte immunoglobulin is not recommended for patients with hypersensitivity to animal-derived proteins or active severe infections.
Substance: anti-lymphocyte immunoglobulin (horse)
Date of last drug list: 10-04-2026
Commercial code: W68563001
Concentration: 50mg / ml
Pharmaceutical form: concentrate for solution for infusion
Quantity: 5
Product type: original
Price: 14499.46 RON
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).
Manufacturer: PFIZER SERVICE COMPANY BV - BELGIA
Holder: PFIZER EUROPE MA EEIG - BELGIA
Number: 14292/2022/01
Shelf life: 2 years-after packaging for sale; after reconstitution-24h